Global TNF Inhibitors Market 2019-2023

Below are some of the key findings from the TNF inhibitors market research report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Get a FREE sample now!

Global TNF inhibitors industry overview

TNF inhibitors have shown high efficacy in the treatment of various autoimmune disorders. Due to this high efficacy coupled with the growing prevalence of autoimmune disorders, the TNS inhibitors market pipeline is witnessing heavy investments. Various companies are focused on developing drugs to treat autoimmune disorders, with several being in the clinical trial stages. For instance, a monoclonal antibody TNF inhibitor approved for the treatment of ankylosing spondylitis is in Phase III stage of clinical trials for the treatment of juvenile rheumatoid arthritis (RA). Many of these pipeline drugs are expected to be launched during the forecast period, incrementing TNF inhibitors market size and driving the TNF inhibitors market growth.

The advent of biosimilars is one of the key TNF inhibitors market trends that will further stimulate market growth. Currently, the global TNF inhibitors market has five approved biologics. With many approved biologics nearing patent expiration, the market is witnessing an increase in the number of biosimilars. About 50 biosimilars are being developed for the treatment of various conditions, with a sizeable share for treatment of autoimmune disorders. Biosimilars are cost effective and are preferred due to their ease of access and similar efficacy to original biologics. Biosimilars get preferred treatment from regulatory authorities for their approval and launch, as they result in cost savings for the federal healthcare budget. Such approaches from regulatory authorities help in quick launch of these biosimilars, which drives the market growth. The TNF inhibitors market is expected to grow at a CAGR of almost 10% during the forecast period.

Top TNF inhibitors companies covered in this market research report

The TNF inhibitors market is moderately concentrated with a few key players occupying the majority of the market share. By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this TNF inhibitors industry analysis report is designed to aid clients identify and build new growth strategies.

The report offers a complete analysis of various companies including:

• AbbVie
• Amgen
• Johnson & Johnson
• Novartis
• Pfizer
• UCB

TNF inhibitors market segmentation based on geographic regions

• Americas
• APAC
• EMEA

The Americas will lead the TNF inhibitors market share during the forecast period. Whereas, in terms of growth rate, the APAC region will witness a slightly faster momentum compared to the other regions.

TNF inhibitors market segmentation based on indication

• TNF inhibitors for RA
• TNF inhibitors for psoriasis
• TNF inhibitors for IBD
• Others

TNF inhibitors for RA will account for the largest TNF inhibitors market share during the forecast period. Whereas, TNF inhibitors for psoriasis will witness the fastest growth rate. Additionally, the report will also provide an accurate prediction of the contribution of the various segments to the growth of the TNF inhibitors market size.

Key highlights of the global TNF inhibitors market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the TNF inhibitors market during the next five years
• Precise estimation of the global TNF inhibitors market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the TNF inhibitors industry across the Americas, APAC, and EMEA
• A thorough analysis of the market's competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of the TNF inhibitors companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch